ArticleThe Journal of clinical investigation2015

Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies.

Zhaoyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.